Faith and Ingenuity: Bringing the First Oncology Clinical Trial to Trinidad
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
Progress Against Cancer
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent breast cancer.
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
Getting more calcium could lower risk for colorectal cancer, and research provides new insight into which BRCA2 mutations can lead to cancer.
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and Scarlett Lin Gomez.
Androgen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
The AACR Cancer Progress Report 2024 detailed the connection between alcohol consumption and the increased risk of certain cancers.
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for patients with breast cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More